{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T16:16:18Z","timestamp":1788365778602,"version":"build-2803163510"},"reference-count":26,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R44 CA224737-01"],"award-info":[{"award-number":["R44 CA224737-01"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ymthe.2026.07.005","type":"journal-article","created":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T12:53:06Z","timestamp":1783601586000},"page":"5257-5272","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["The oncolytic viral immunotherapy ASP1012 optimizes memory T cell responses after systemic delivery"],"prefix":"10.1016","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1579-1664","authenticated-orcid":false,"given":"Ravikumar","family":"Muthuswamy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carly","family":"Carter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-3163-7666","authenticated-orcid":false,"given":"Padma","family":"Sampath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Acosta-Barreto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sydney","family":"Audino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-4170-8917","authenticated-orcid":false,"given":"Jirapach","family":"Moongdee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Bouchard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deanna","family":"Dunstane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick","family":"Matteo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle","family":"Biery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Cantos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brianna","family":"Wilkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinsuke","family":"Nakao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahisa","family":"Hemmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly M.","family":"Brothers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-8494-9128","authenticated-orcid":false,"given":"Stephen H.","family":"Thorne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2026.07.005_bib1","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aax7992","article-title":"Intratumoral expression of IL-7 and IL-12 using an oncolytic virus increases systemic sensitivity to immune checkpoint blockade","volume":"12","author":"Nakao","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2026.07.005_bib2","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.immuni.2019.07.003","article-title":"Oncolytic Viruses Engineered to Enforce Leptin Expression Reprogram Tumor-Infiltrating T Cell Metabolism and Promote Tumor Clearance","volume":"51","author":"Rivadeneira","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.ymthe.2026.07.005_bib3","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1126\/science.181845","article-title":"Selective in Vitro Growth of T Lymphocytes from Normal Human Bone Marrows","volume":"193","author":"Morgan","year":"1976","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2026.07.005_bib4","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/cncr.23552","article-title":"High-dose interleukin-2 for the treatment of metastatic renal cell carcinoma: A retrospective analysis of response and survival in patients treated in the surgery branch at the National Cancer Institute between 1986 and 2006","volume":"113","author":"Klapper","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.ymthe.2026.07.005_bib5","first-page":"S11","article-title":"High-dose recombinant interleukin-2 therapy in patients with metastatic melanoma: long-term survival update","volume":"6","author":"Atkins","year":"2000","journal-title":"Cancer J. Sci. Am."},{"key":"10.1016\/j.ymthe.2026.07.005_bib6","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1089\/jir.2017.0101","article-title":"IL-2 and Beyond in Cancer Immunotherapy","volume":"38","author":"Wrangle","year":"2018","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.ymthe.2026.07.005_bib7","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/9056173","article-title":"Prospects of IL-2 in Cancer Immunotherapy","volume":"2018","author":"Choudhry","year":"2018","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.ymthe.2026.07.005_bib8","doi-asserted-by":"crossref","first-page":"157","DOI":"10.4049\/jimmunol.134.1.157","article-title":"In vivo administration of purified human interleukin 2. I. Half-life and immunologic effects of the Jurkat cell line-derived interleukin 2","volume":"134","author":"Lotze","year":"1985","journal-title":"J. Immunol."},{"key":"10.1016\/j.ymthe.2026.07.005_bib9","first-page":"11","article-title":"Managing toxicities of high-dose interleukin-2","volume":"16","author":"Schwartz","year":"2002","journal-title":"Oncology (Williston Park)"},{"key":"10.1016\/j.ymthe.2026.07.005_bib10","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20191247","article-title":"Effects of interleukin-2 in immunostimulation and immunosuppression","volume":"217","author":"Pol","year":"2020","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ymthe.2026.07.005_bib11","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1038\/ni.3540","article-title":"An essential role for the IL-2 receptor in Treg cell function","volume":"17","author":"Chinen","year":"2016","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ymthe.2026.07.005_bib12","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/s41590-020-00850-9","article-title":"IL-2 regulates tumor-reactive CD8+ T cell exhaustion by activating the aryl hydrocarbon receptor","volume":"22","author":"Liu","year":"2021","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ymthe.2026.07.005_bib13","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1038\/s41423-021-00712-w","article-title":"The two faces of IL-2: a key driver of CD8+ T-cell exhaustion","volume":"18","author":"Kwon","year":"2021","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.ymthe.2026.07.005_bib14","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/mt.2011.276","article-title":"The oncolytic poxvirus JX-594 selectively replicates in and destroys cancer cells driven by genetic pathways commonly activated in cancers","volume":"20","author":"Parato","year":"2012","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.07.005_bib15","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1084\/jem.20021652","article-title":"The Poxvirus Protein A52R Targets Toll-like Receptor Signaling Complexes to Suppress Host Defense","volume":"197","author":"Harte","year":"2003","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ymthe.2026.07.005_bib16","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1743-422X-1-10","article-title":"Susceptibility of different leukocyte cell types to Vaccinia virus infection","volume":"1","author":"S\u00e1nchez-Puig","year":"2004","journal-title":"Virol. J."},{"key":"10.1016\/j.ymthe.2026.07.005_bib17","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1128\/jvi.64.4.1523-1529.1990","article-title":"Vaccinia virus gene encoding a component of the viral early transcription factor","volume":"64","author":"Broyles","year":"1990","journal-title":"J. Virol."},{"key":"10.1016\/j.ymthe.2026.07.005_bib18","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1128\/jvi.66.1.534-547.1992","article-title":"Transient expression of the vaccinia virus DNA polymerase is an intrinsic feature of the early phase of infection and is unlinked to DNA replication and late gene expression","volume":"66","author":"McDonald","year":"1992","journal-title":"J. Virol."},{"key":"10.1016\/j.ymthe.2026.07.005_bib19","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1586\/erv.11.79","article-title":"Vaccinia viruses: vaccines against smallpox and vectors against infectious diseases and tumors","volume":"10","author":"Walsh","year":"2011","journal-title":"Expert Rev. Vaccin."},{"key":"10.1016\/j.ymthe.2026.07.005_bib20","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S0039-6060(03)00294-0","article-title":"The role of poxviruses in tumor immunotherapy","volume":"134","author":"Kaufman","year":"2003","journal-title":"Surgery"},{"key":"10.1016\/j.ymthe.2026.07.005_bib21","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nm.3089","article-title":"Randomized dose-finding clinical trial of oncolytic immunotherapeutic vaccinia JX-594 in liver cancer","volume":"19","author":"Heo","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2026.07.005_bib22","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S1357-4310(97)81456-6","article-title":"Replicating viruses as selective cancer therapeutics","volume":"2","author":"Kirn","year":"1996","journal-title":"Mol. Med. Today"},{"key":"10.1016\/j.ymthe.2026.07.005_bib23","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1099\/0022-1317-83-3-491","article-title":"Cytolytic viruses as potential anti-cancer agents","volume":"83","author":"Ring","year":"2002","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.ymthe.2026.07.005_bib24","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/s41571-022-00719-w","article-title":"Therapy with oncolytic viruses: progress and challenges","volume":"20","author":"Shalhout","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.ymthe.2026.07.005_bib25","doi-asserted-by":"crossref","first-page":"6819","DOI":"10.1128\/JVI.03726-13","article-title":"Primary Human Macrophages Serve as Vehicles for Vaccinia Virus Replication and Dissemination","volume":"88","author":"Byrd","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.ymthe.2026.07.005_bib26","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1046\/j.1523-1747.2002.01725.x","article-title":"The role of chemokines in melanoma tumor growth and metastasis","volume":"118","author":"Payne","year":"2002","journal-title":"J. Invest. Dermatol."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001626005721?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001626005721?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T15:20:35Z","timestamp":1788362435000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001626005721"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":26,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S1525001626005721"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2026.07.005","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The oncolytic viral immunotherapy ASP1012 optimizes memory T cell responses after systemic delivery","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2026.07.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The American Society of Gene and Cell Therapy. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}